New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases

New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases

Coronary heart disease (CHD), mainly caused by atherosclerosis, represents the single leading cause of death in industrialized countries. Besides the classical interventional therapies new applications for treatment of vascular wall pathologies are appearing on the horizon. RNA interference (RNAi) r...

Full description

Bibliographic Details
Main Authors: Hans-Peter Wendel, Bernd Neumann, Christian Schlensak, Almuth Zech, Nadja Perle, Olivia Koenig, Tobias Walker, Andrea Nolte
Format: Article
Language:English
Published: MDPI AG 2013-07-01
Series:Pharmaceuticals
Subjects:
RNAi
siRNA
ASO
transfection tools
delivery systems
atherosclerosis
CVD (cardiovascular disease)
restenosis
drug eluting stents
Online Access:http://www.mdpi.com/1424-8247/6/7/881

Internet

http://www.mdpi.com/1424-8247/6/7/881

Similar Items